Integra Lifesciences Holdings (IART) Amortizatization of Intangibles (2011 - 2026)
Integra Lifesciences Holdings (IART) posted Amortizatization of Intangibles of $1.0 million for Q2 2026, up 2.51% sequentially from $995000.0 in Q1 2026, and down 46.03% YoY from $1.9 million in Q2 2025.
Integra Lifesciences Holdings (IART) Amortizatization of Intangibles (2011 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Amortizatization of Intangibles for 14 years, with the latest figure at $1.0 million in Q2 2026.
- Quarterly Amortizatization of Intangibles fell 46.03% year-over-year to $1.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.3 million (down 27.7% YoY) and the FY2025 annual result came in at $5.6 million, changed 0.21% from the prior year.
- Amortizatization of Intangibles rose to $1.0 million in Q2 2026 per IART's latest filing, from $995000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.9 million in Q1 2023 and troughed at $995000.0 in Q1 2026.
- A 5-year average of $1.5 million and a median of $1.4 million in 2023 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles gained 29.45% in 2025, then slumped 46.03% in 2026.
- Over 5 years, Amortizatization of Intangibles stood at $1.7 million in 2022, then retreated by 15.85% to $1.4 million in 2023, then retreated by 2.3% to $1.4 million in 2024, then dropped by 27.5% to $1.0 million in 2025, then advanced by 0.49% to $1.0 million in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1.0 million, $995000.0, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 995,000.00 |
| Mar 31, 2026 | 995,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 1.89 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.40 Mn |